Annexon (ANNX) News Today $2.82 -0.01 (-0.25%) As of 03:25 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Jamie Dananberg Sells 5,521 Shares of Annexon, Inc. (NASDAQ:ANNX) StockFebruary 21 at 7:10 AM | insidertrades.comDouglas Love Sells 5,021 Shares of Annexon, Inc. (NASDAQ:ANNX) StockAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) CEO Douglas Love sold 5,021 shares of the business's stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $2.95, for a total value of $14,811.95. Following the sale, the chief executive officer now owns 351,554 shares of the company's stock, valued at approximately $1,037,084.30. The trade was a 1.41 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.February 19 at 5:16 PM | marketbeat.comAnnexon reports inducement grants under Nasdaq listing ruleFebruary 19 at 4:43 AM | markets.businessinsider.comAnalysts Set Annexon, Inc. (NASDAQ:ANNX) Target Price at $15.80February 19 at 1:33 AM | americanbankingnews.comAnnexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)February 18 at 8:00 AM | globenewswire.comAnnexon, Inc. (NASDAQ:ANNX) Short Interest Up 8.3% in JanuaryAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) was the recipient of a significant increase in short interest in January. As of January 31st, there was short interest totalling 10,090,000 shares, an increase of 8.3% from the January 15th total of 9,320,000 shares. Based on an average trading volume of 1,420,000 shares, the days-to-cover ratio is currently 7.1 days.February 17, 2025 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Given Consensus Recommendation of "Buy" by BrokeragesAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) has earned an average recommendation of "Buy" from the six analysts that are covering the stock, MarketBeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have issued raFebruary 16, 2025 | marketbeat.comAnnexon Announces Presentations Highlighting ANX007 Functional and Structural Differentiation in Geographic Atrophy at the Macula Society 48th Annual MeetingFebruary 13, 2025 | globenewswire.comAnnexon stock hits 52-week low at $3.04 amid market challengesFebruary 12, 2025 | msn.comShort Interest in Annexon, Inc. (NASDAQ:ANNX) Increases By 23.7%Annexon, Inc. (NASDAQ:ANNX - Get Free Report) was the target of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 8,980,000 shares, an increase of 23.7% from the December 31st total of 7,260,000 shares. Based on an average daily trading volume, of 1,340,000 shares, the short-interest ratio is currently 6.7 days.January 30, 2025 | marketbeat.comCantor Fitzgerald Estimates Annexon FY2025 EarningsAnnexon, Inc. (NASDAQ:ANNX - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Annexon in a research report issued on Tuesday, January 21st. Cantor Fitzgerald analyst P. Stavropoulos anticipates that the company will earn ($0.99) per shareJanuary 22, 2025 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Given Average Rating of "Buy" by BrokeragesShares of Annexon, Inc. (NASDAQ:ANNX - Get Free Report) have been assigned an average recommendation of "Buy" from the six research firms that are currently covering the stock, MarketBeat reports. Six analysts have rated the stock with a buy recommendation. The average 1-year target price among anJanuary 22, 2025 | marketbeat.comHennion & Walsh Asset Management Inc. Has $2.20 Million Stock Position in Annexon, Inc. (NASDAQ:ANNX)Hennion & Walsh Asset Management Inc. increased its stake in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 65.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 429,584 shares of the company's stock aJanuary 18, 2025 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Sees Large Increase in Short InterestAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 8,980,000 shares, an increase of 23.7% from the December 15th total of 7,260,000 shares. Based on an average trading volume of 1,340,000 shares, the short-interest ratio is currently 6.7 days.January 16, 2025 | marketbeat.comBarclays PLC Acquires 120,789 Shares of Annexon, Inc. (NASDAQ:ANNX)Barclays PLC raised its stake in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 212.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 177,765 shares of the company's stock after buying an additional 120,789 sharesJanuary 15, 2025 | marketbeat.comAnnexon announces 2025 strategic priorities, key catalystsJanuary 13, 2025 | markets.businessinsider.comAnnexon Provides 2025 Outlook with Strong Momentum Accelerating into Breakthrough YearJanuary 13, 2025 | markets.businessinsider.comJPMorgan Chase & Co. Has $10.10 Million Stake in Annexon, Inc. (NASDAQ:ANNX)JPMorgan Chase & Co. increased its position in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 16.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,706,182 shares of the company's stock after buying an addiJanuary 13, 2025 | marketbeat.comAnnexon Expands Board of Directors with Appointment of Commercial Executive William “BJ” JonesJanuary 10, 2025 | finance.yahoo.comAnnexon appoints William Jones to board of directorsJanuary 10, 2025 | markets.businessinsider.comAnnexon Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 7, 2025 | globenewswire.comAnnexon (NASDAQ:ANNX) Stock Price Down 4.3% - What's Next?Annexon (NASDAQ:ANNX) Stock Price Down 4.3% - What's Next?January 6, 2025 | marketbeat.comGeode Capital Management LLC Grows Stake in Annexon, Inc. (NASDAQ:ANNX)Geode Capital Management LLC increased its holdings in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 18.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,143,635 shares of the company's stockDecember 31, 2024 | marketbeat.comBarclays PLC Has $1.05 Million Holdings in Annexon, Inc. (NASDAQ:ANNX)Barclays PLC boosted its stake in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 212.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 177,765 shares of the company's stock after buying an additional 120December 31, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Annexon, Inc. (NASDAQ:ANNX - Get Free Report) have been given a consensus recommendation of "Buy" by the six research firms that are covering the company, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average twelve-month target price amongDecember 28, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Shares Purchased by State Street CorpState Street Corp raised its stake in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 116.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,841,879 shares of the company's stock after purchasing an additional 2,068,2December 23, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Trading Down 3.8% - Here's WhyAnnexon (NASDAQ:ANNX) Stock Price Down 3.8% - Here's What HappenedDecember 19, 2024 | marketbeat.comPromising Real-World Evidence Boosts Buy Rating for Annexon’s ANX005 in GBS TreatmentDecember 18, 2024 | markets.businessinsider.comAnnexon's (ANNX) Buy Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and set a $30.00 price target on shares of Annexon in a report on Tuesday.December 17, 2024 | marketbeat.comBuy Rating for Annexon Biosciences: ANX005 Shows Promising Results in GBS TreatmentDecember 17, 2024 | markets.businessinsider.comAnnexon Biosciences Positioned for Success with Promising ANX005 Study in GBSDecember 17, 2024 | markets.businessinsider.comAnnexon Announces Topline Data From RWE Study Of ANX005 For Guillain-Barré Syndrome, Stock UpDecember 16, 2024 | markets.businessinsider.comAnnexon Biosciences’ ANX005: Strong Buy Rating Backed by Promising Efficacy and Sales PotentialDecember 16, 2024 | markets.businessinsider.comAnnexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)December 16, 2024 | globenewswire.comAnnexon (NASDAQ:ANNX) Shares Gap Up - Here's What HappenedAnnexon (NASDAQ:ANNX) Shares Gap Up - Still a Buy?December 16, 2024 | marketbeat.comAnnexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS)December 16, 2024 | globenewswire.comCharles Schwab Investment Management Inc. Has $4.34 Million Stake in Annexon, Inc. (NASDAQ:ANNX)Charles Schwab Investment Management Inc. increased its position in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 221.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 732,216 shares of the company's stock after buying anDecember 14, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Stock Holdings Raised by Fmr LLCFmr LLC lifted its stake in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 3.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 8,561,949 shares of the company's stock after purchasing an additional 262,229 shares during the period. Fmr LLCDecember 8, 2024 | marketbeat.comPoint72 Asset Management L.P. Sells 662,019 Shares of Annexon, Inc. (NASDAQ:ANNX)Point72 Asset Management L.P. lessened its holdings in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 11.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,326,998 shares of the comDecember 6, 2024 | marketbeat.comAnnexon to present Phase 2 ARCHER DATA on ANX007December 5, 2024 | markets.businessinsider.comAnnexon, Inc. (NASDAQ:ANNX) Director Buys $17,056.00 in StockDecember 5, 2024 | insidertrades.comReadystate Asset Management LP Has $4.59 Million Holdings in Annexon, Inc. (NASDAQ:ANNX)Readystate Asset Management LP cut its holdings in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 12.3% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 774,860 shares of the company's stock after selling 108,588 shares duDecember 5, 2024 | marketbeat.comWalleye Capital LLC Purchases Shares of 328,698 Annexon, Inc. (NASDAQ:ANNX)Walleye Capital LLC purchased a new stake in Annexon, Inc. (NASDAQ:ANNX - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 328,698 shares of the company's stock, valued at approximately $1,946,000. WDecember 5, 2024 | marketbeat.comSio Capital Management LLC Acquires Shares of 1,433,155 Annexon, Inc. (NASDAQ:ANNX)Sio Capital Management LLC bought a new position in Annexon, Inc. (NASDAQ:ANNX - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,433,155 shares of the company's stock, valNovember 29, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Shares Purchased by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA grew its holdings in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 9.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,160,886 shares of the company's stock after purchasiNovember 27, 2024 | marketbeat.comFY2027 Earnings Forecast for Annexon Issued By HC WainwrightAnnexon, Inc. (NASDAQ:ANNX - Free Report) - Stock analysts at HC Wainwright dropped their FY2027 EPS estimates for Annexon in a note issued to investors on Friday, November 15th. HC Wainwright analyst A. Fein now forecasts that the company will post earnings per share of $0.49 for the year, downNovember 18, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Short Interest Down 12.9% in OctoberAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) was the recipient of a significant decline in short interest in October. As of October 31st, there was short interest totalling 7,770,000 shares, a decline of 12.9% from the October 15th total of 8,920,000 shares. Based on an average daily trading volume, of 1,270,000 shares, the days-to-cover ratio is presently 6.1 days.November 16, 2024 | marketbeat.comAnnexon Biosciences’ Promising Future: Buy Rating Backed by Strategic Decisions and Financial StabilityNovember 15, 2024 | markets.businessinsider.comAnnexon Biosciences: Promising Phase 3 Results and Pipeline Potential Justify Buy RatingNovember 15, 2024 | markets.businessinsider.comAnnexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)November 15, 2024 | globenewswire.com Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Email Address ANNX Media Mentions By Week ANNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANNX News Sentiment▼0.420.60▲Average Medical News Sentiment ANNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANNX Articles This Week▼133▲ANNX Articles Average Week Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SNDX News Today ARVN News Today ANIP News Today DAWN News Today ADPT News Today RCUS News Today CALT News Today SYRE News Today SPRY News Today OCUL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANNX) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Annexon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Annexon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANNX Stock Alerts